Apellis Pharmaceuticals, Inc. short interest in 2023
In 2023, Apellis Pharmaceuticals, Inc.'s disclosed short interest ran from 8.67% of shares outstanding on 13 Jan 2023 to 9.86% on 29 Dec 2023, a change of +1.19 percentage points. The year's high was 15.79% on 13 Oct 2023 and its low 8.14% on 14 Jul 2023, averaging 10.65% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.98 days on 14 Jul 2023. Full history: Apellis Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 8.67% (13 Jan 2023)
- End of year
- 9.86% (29 Dec 2023)
- Change
- +1.19 pp
- High
- 15.79% (13 Oct 2023)
- Low
- 8.14% (14 Jul 2023)
- Average
- 10.65%
- Highest days to cover
- 11.98 (14 Jul 2023)
- SEC filings marked
- 6
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 8.67% | 8.59 | |
| 31 Jan 2023 | 8.24% | 9.01 | |
| 15 Feb 2023 | 8.19% | 6.43 | |
| 28 Feb 2023 | 9.71% | 2.99 | 10-K filed |
| 15 Mar 2023 | 10.99% | 7.06 | |
| 31 Mar 2023 | 11.11% | 8.21 | |
| 14 Apr 2023 | 11.15% | 5.89 | |
| 28 Apr 2023 | 9.30% | 6.18 | |
| 15 May 2023 | 9.45% | 6.12 | 10-Q filed |
| 31 May 2023 | 9.75% | 9.18 | |
| 15 Jun 2023 | 9.84% | 10.10 | |
| 30 Jun 2023 | 8.24% | 3.66 | |
| 14 Jul 2023 | 8.14% | 11.98 | |
| 31 Jul 2023 | 8.16% | 1.00 | 10-Q filed, results (8-K) |
| 15 Aug 2023 | 11.68% | 1.90 | |
| 31 Aug 2023 | 10.45% | 3.58 | |
| 15 Sep 2023 | 11.56% | 7.35 | |
| 29 Sep 2023 | 14.25% | 4.62 | |
| 13 Oct 2023 | 15.79% | 6.32 | results (8-K) |
| 31 Oct 2023 | 13.70% | 9.58 | |
| 15 Nov 2023 | 13.62% | 7.53 | 10-Q filed |
| 30 Nov 2023 | 12.88% | 10.43 | |
| 15 Dec 2023 | 10.95% | 3.34 | |
| 29 Dec 2023 | 9.86% | 6.52 |
See also: Apellis Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.